Shadow

Search

advanced search
search help

Blog Archives

ipHandbook Blog
Product-Development Partnerships (PDP) Archive

IP Handbook ContentAvailable on IP Handbook Site

April 16, 2010

Stockholm Network Polybrief: Standards, Competition and Innovation - April 2010

Posted by Shashwat on April 16, 2010 at 1:27 pm 

The Stockholm Network is delighted to announce a new policy briefing note, which explores the debate around standards, competition and innovation. As well as providing background on the relationship between intellectual property rights and open standards, the Polybrief also explores the debate between open and proprietary-based standards, as well as identifying and outlining new governmental approaches to standards.
Stockholm Network Polybriefs provide concise summaries of pressing issues and policy debate throughout Europe.
To view this Polybrief, please visit : http://www.stockholm-network.org/downloads/publications/Standards_Polybrief.pdf

We hope you will find this of interest and we look forward to hearing from you,
Stockholm Network

Categories: Access and Benefit Sharing (ABS), Events, Policy, Product-Development Partnerships (PDP), Public-Private Partnerships (PPP)  |  Comments (0)

October 12, 2009

Development of ‘The Triple Helix Model’ In Technology Transfer – I

Posted by Shashwat on October 12, 2009 at 4:52 am 

At its essence, the triple helix model is a partnership between the industrial, academia and governmental groups which recognizes the differing goals and stakeholder communities of these three groups but emphasizes on the common interest of those groups in order to provide value to the societies in which they reside. It is often operationalized as cosponsored programs. These programs support both small and large firms to transfer technologies from government and academic research laboratories and have enabled societies to more greatly benefit from the technological research that those same societies fund.

The landmark attempt towards the triple helix model was made by the U.S. when it enacted the Bayh-Dole legislation in 1980. This legislation granted permission for federally funded researchers to file for patents, and to issue licenses for these patents to other parties, thereby increasing participating of U.S. universities in national patenting. Conversely, in Eastern Europe, during the transition from socialism, some reformers were trying to remove government from a role in science and technology policy. Innovation systems were largely coming to a halt. Even though foreign direct investment was encouraged, it seldom involved utilizing local R&D resources. More recently, political leaders are moving away from that rigid position and bringing government back into the picture to take advantage of the R&D resources left behind from the previous era.

In the U.S., government-industry relations assumed increased significance in the 1990s even as university-industry bonds came to the forefront of attention in the 1980s. In much of the European Community these two sets of bilateral relations developed in reverse sequence with academic-industry connections following upon the development of government-industry relations. Academic-industry-government relations in the U.S. are taking on the cast that government-industry labor relations have long had in Europe. In the EU, EU sponsored activities, other efforts by European governments, NEXUS, IVAM are all examples of Government, Academia and Industry working together in order to maximize the commercial potential of macro and nano technologies in Europe.

This post in Part I on the larger area I intend to cover on the triple helix model for Technology Transfer on this blog.

References and Suggested reading:

  1. Dr. Steven Walsh, ‘The Use of the Triple Helix Concept in Accelerating the Pace of Commercialization of Micro and Nano Technology Based Products’, available at http://www.cmc.ca/news/events/cwmems01/presentations/walsh.pdf
  2. Richard Barras, ‘Interactive Innovation in Financial and Business Services:  The vanguard of the Service Revolution,” Research Policy, 19 (1990) 215- 37.
  3. Loet Leydesdorff & Martin Meyer, ‘The Decline of University Patenting & the End of the Bayh-Dole Effect’, Scientometrics, available at http://users.fmg.uva.nl/lleydesdorff/Bayh-Dole/index.htm
  4. Henry Etzkowitz, “The Bi-Evolution of the University in the Triple Helix Era,” available at http://www.ie.ufrj.br/eventos/seminarios/pesquisa/a_universidade_e_o_desenvolvimento_regional.pdf.

Categories: Access and Benefit Sharing (ABS), European Union, Intellectual Property, Product-Development Partnerships (PDP), Public-Private Partnerships (PPP), Uncategorized, patents  |  Comments (0)

March 27, 2009

Product-Development Partnerships May Be the Answer to Child Malnutrition

Posted by Brian on March 27, 2009 at 9:38 am 

“I see a system failing. It is doing something, but it is not solving the problem.” These were the words uttered by Purnima Menon, a public health researcher with the International Food Policy Research Institute and reported in a New York Times article on March 13, 2009. She was referring to the rampant malnutrition evident among children in India. Almost half of all children under three years of age are underweight or severely underweight and malnutrition among children accounts for more than one-fifth of the total disease burden. Surprisingly, this staggering rate of malnutrition is occurring in a country that has one of the fastest growing economies in the world and has shown substantial economic growth for over a decade.

Certainly prioritizing funding to this area is part of the problem both at the national (Amartya Sen, a Nobel prize-winning economist, noted that hunger was not enough of a political priority in India) and international levels (Ruth Levine noted in her blog that malnourishment is well known to be severely under-funded internationally). Yet, insufficient funding alone does not tell the whole story. India runs the largest child feeding program in the world and has a $1.3 billion Integrated Child Development Services program to combat malnutrition via financing a network of soup kitchens in slums and villages. Despite this substantial investment, the program has been, for the most part, unsuccessful largely due to the fact that the program is not well designed and does not adequately target the groups most in need of their services (i.e., children). For instance, the New York Times article noted above described one center in which there were no children; instead the food was being given to the few adults who showed up. It has been argued that this problem, which is reflected at the international level, is due to a lack of leadership and governance (see Source 3).

Many believe that the solution is greater governmental intervention. The author of a Lancet article addressing this issue back in January 2008 wrote, “The compelling logic of this scientific evidence is that governments need national plans to scale-up nutrition interventions, systems to monitor and evaluate those plans, and laws and policies to enhance the rights and status of women and children.” Likewise, a blog published on March 13, 2009 (Hanging in the Balance: Who Will Deal with Child Malnutrition?) argued for increased governmental (both at the local and international level) attention and action.

Given the demonstrated success of PDPs in the area of drug development for neglected diseases in developing countries, it is somewhat baffling why a similar approach has not been more aggressively pursued in this area. The hurdles preventing programs from successfully managing malnutrition seem to be similar to those present in developing drugs for neglected diseases. As has been noted, the primary impediment in India (and arguably in other developing countries) has been a lack of implementation and efficient use of resources. These are the very areas that the private sector excels at addressing. It has been frequently observed in the areas of vaccine distribution and health care innovations that the strength of the private sector is reaching markets and dealing with regulatory challenges (see Sources 4 & 5) while the public sector brings to the table a thorough knowledge of the needs of the country (i.e., areas that are most effected by child malnutrition).

There are some who might argue that the lack of short-term commercial returns would deter private sector involvement. We find this argument to be both unpersuasive and unsupported by the data. Regarding the funding of neglected disease projects, Mary Moran reported that commercial incentives were largely irrelevant to large companies. Rather long-term business considerations such as “positioning themselves in emerging developing country markets, or building access to low-cost, high-skilled developing country researchers” were the primary motivators.

This idea of using PDPs is not novel despite the fact that it appears to be underutilized in the area of child malnutrition. Three years ago almost to the day (March 9, 2006) a document was released entitled Tackling Child Malnutrition Through Market/PPPs: An emerging trend. In this document the director of the UNICEF Nutrition Program in India observed that “solutions from a technical point of view are known, but the lack of collaboration between government, NGOs, and companies, together with obstacles inherent in existing structures, prevent real progress. In addition, the business community’s involvement is limited mostly to providing philanthropy, rather than developing and offering market-based solutions.” In light of this, and past demonstrated successes of PDPs, one has to wonder why a greater amount of attention and resources are not being put into developing PDPs.

Additional Sources

1. What works? Interventions for maternal and child undernutrition and survival

2. Effective international action against undernutrition: why has it proven so difficult and what can be done to accelerate progress?

3. Horton, R. (2008). Maternal and child undernutrition: an urgent opportunity, Lancet, 371, 179.

4. Mahoney, R.T., Krattiger, A., Clemens, J.D., and Curtiss, R. (2007). The introduction of new vaccines into developing countries IV: Global Access Strategies. Vaccine, 25, 4003-4011.

5. Mahoney, R.T. and Morel, C.M. (2006). A global health innovation system (GHIS). Innovation Strategy Today, 2, 1-12.

6. Moran, M. (2005). A Breakthrough in R&D for Neglected Diseases: New Ways to Get the Drugs We Need. PLoS Medicine, 2, e302.

Brian Harel and Jason Kasting

Categories: Health, Product-Development Partnerships (PDP), Public-Private Partnerships (PPP)  |  Comments (0)